| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | low-affinity IgG receptor activity | 4.05e-06 | 4 | 202 | 3 | GO:0019772 | |
| GeneOntologyMolecularFunction | semaphorin receptor activity | 4.72e-06 | 12 | 202 | 4 | GO:0017154 | |
| GeneOntologyMolecularFunction | IgG receptor activity | 3.46e-05 | 7 | 202 | 3 | GO:0019770 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 7.61e-05 | 70 | 202 | 6 | GO:0003777 | |
| GeneOntologyMolecularFunction | cholesterol dehydrogenase activity | 1.02e-04 | 2 | 202 | 2 | GO:0102294 | |
| GeneOntologyMolecularFunction | IgG binding | 1.59e-04 | 11 | 202 | 3 | GO:0019864 | |
| GeneOntologyMolecularFunction | filamin binding | 1.98e-04 | 29 | 202 | 4 | GO:0031005 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.00e-04 | 118 | 202 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | immunoglobulin receptor activity | 3.42e-04 | 14 | 202 | 3 | GO:0019763 | |
| GeneOntologyMolecularFunction | immunoglobulin binding | 4.65e-04 | 36 | 202 | 4 | GO:0019865 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | SETX MYO9B ABCA7 STARD9 ATP11A KIF5B KIFC1 ATG7 KIF26B RNF213 ZNFX1 DNAH1 KIF20A ABCB10 ENTPD2 HELZ2 | 5.34e-04 | 614 | 202 | 16 | GO:0140657 |
| GeneOntologyBiologicalProcess | antibody-dependent cellular cytotoxicity | 1.09e-07 | 13 | 204 | 5 | GO:0001788 | |
| GeneOntologyBiologicalProcess | type IIa hypersensitivity | 2.50e-07 | 15 | 204 | 5 | GO:0001794 | |
| GeneOntologyBiologicalProcess | type II hypersensitivity | 2.50e-07 | 15 | 204 | 5 | GO:0002445 | |
| GeneOntologyBiologicalProcess | hypersensitivity | 4.08e-06 | 25 | 204 | 5 | GO:0002524 | |
| GeneOntologyBiologicalProcess | Fc receptor-mediated immune complex endocytosis | 3.24e-05 | 7 | 204 | 3 | GO:0160006 | |
| GeneOntologyBiologicalProcess | positive regulation of type I hypersensitivity | 5.15e-05 | 8 | 204 | 3 | GO:0001812 | |
| GeneOntologyBiologicalProcess | acute inflammatory response to antigenic stimulus | 5.69e-05 | 42 | 204 | 5 | GO:0002438 | |
| GeneOntologyBiologicalProcess | regulation of type I hypersensitivity | 7.66e-05 | 9 | 204 | 3 | GO:0001810 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | SETX PDGFRB LRRTM3 ABCA7 ANKRD27 NRP1 MET FCGR2A ATF7IP2 HRG EPS8L3 KIF5B DDHD2 STK24 PLXNA1 STK25 DPYSL3 DRD3 LRRN1 P2RY12 RB1 POT1 MCOLN1 VPS13D IGHG1 IGHG3 PLXNA4 PLCE1 NCKAP1L | 8.16e-05 | 1366 | 204 | 29 | GO:0051130 |
| GeneOntologyBiologicalProcess | perforin production | 9.73e-05 | 2 | 204 | 2 | GO:0035944 | |
| GeneOntologyBiologicalProcess | positive regulation of type IIa hypersensitivity | 1.09e-04 | 10 | 204 | 3 | GO:0001798 | |
| GeneOntologyBiologicalProcess | type I hypersensitivity | 1.09e-04 | 10 | 204 | 3 | GO:0016068 | |
| GeneOntologyBiologicalProcess | positive regulation of type II hypersensitivity | 1.09e-04 | 10 | 204 | 3 | GO:0002894 | |
| GeneOntologyBiologicalProcess | regulation of type IIa hypersensitivity | 1.48e-04 | 11 | 204 | 3 | GO:0001796 | |
| GeneOntologyBiologicalProcess | regulation of type II hypersensitivity | 1.48e-04 | 11 | 204 | 3 | GO:0002892 | |
| GeneOntologyBiologicalProcess | branching involved in salivary gland morphogenesis | 1.58e-04 | 28 | 204 | 4 | GO:0060445 | |
| GeneOntologyBiologicalProcess | semaphorin-plexin signaling pathway | 1.61e-04 | 52 | 204 | 5 | GO:0071526 | |
| GeneOntologyCellularComponent | cell surface | CEACAM5 PDGFRB NCAM1 THSD1 ABCA7 DSCAML1 GFRA1 NRP1 CD84 SLC38A1 MET CEACAM21 FCGR2A FCGR3A FCGR3B HRG CD99L2 ADGRA3 SLAMF9 P2RY12 VASN PKD2L1 LCT LEPR IGHG1 IGHG3 VCAN ENTPD2 TNS1 | 1.60e-06 | 1111 | 206 | 29 | GO:0009986 |
| GeneOntologyCellularComponent | external encapsulating structure | PRSS3 IL16 NCAM1 LRRTM3 DST AEBP1 HRG COL4A6 HSPG2 ZAN LRRN1 VASN LAMA5 RPSA PKHD1L1 EYS HMCN1 VCAN ENTPD2 OTOG | 8.66e-06 | 658 | 206 | 20 | GO:0030312 |
| GeneOntologyCellularComponent | extracellular matrix | PRSS3 IL16 NCAM1 LRRTM3 DST AEBP1 HRG COL4A6 HSPG2 ZAN LRRN1 VASN LAMA5 RPSA EYS HMCN1 VCAN ENTPD2 OTOG | 2.85e-05 | 656 | 206 | 19 | GO:0031012 |
| GeneOntologyCellularComponent | external side of plasma membrane | CEACAM5 NCAM1 GFRA1 CD84 SLC38A1 CEACAM21 FCGR2A FCGR3A FCGR3B ADGRA3 SLAMF9 P2RY12 LCT LEPR IGHG1 IGHG3 | 6.01e-05 | 519 | 206 | 16 | GO:0009897 |
| GeneOntologyCellularComponent | basement membrane | 2.10e-04 | 122 | 206 | 7 | GO:0005604 | |
| GeneOntologyCellularComponent | semaphorin receptor complex | 2.51e-04 | 13 | 206 | 3 | GO:0002116 | |
| GeneOntologyCellularComponent | intercellular bridge | 3.37e-04 | 94 | 206 | 6 | GO:0045171 | |
| GeneOntologyCellularComponent | Fc-gamma receptor III complex | 5.72e-04 | 4 | 206 | 2 | GO:0033001 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | PRSS3 IL16 NCAM1 DST AEBP1 HRG COL4A6 HSPG2 LAMA5 RPSA EYS HMCN1 VCAN ENTPD2 | 8.16e-04 | 530 | 206 | 14 | GO:0062023 |
| GeneOntologyCellularComponent | side of membrane | CEACAM5 NCAM1 GFRA1 CD84 TYK2 SLC38A1 DST CEACAM21 FCGR2A FCGR3A FCGR3B ADGRA3 SLAMF9 P2RY12 LCT LEPR THADA IGHG1 IGHG3 | 1.09e-03 | 875 | 206 | 19 | GO:0098552 |
| GeneOntologyCellularComponent | external side of apical plasma membrane | 1.41e-03 | 6 | 206 | 2 | GO:0098591 | |
| GeneOntologyCellularComponent | super elongation complex | 1.41e-03 | 6 | 206 | 2 | GO:0032783 | |
| GeneOntologyCellularComponent | interphotoreceptor matrix | 1.41e-03 | 6 | 206 | 2 | GO:0033165 | |
| MousePheno | abnormal gustatory papilla taste bud morphology | 3.09e-05 | 6 | 164 | 3 | MP:0006260 | |
| MousePheno | abnormal germinal center B cell number | 4.29e-05 | 55 | 164 | 6 | MP:0013680 | |
| MousePheno | abnormal germinal center B cell morphology | 4.29e-05 | 55 | 164 | 6 | MP:0008176 | |
| MousePheno | abnormal taste bud morphology | 5.36e-05 | 7 | 164 | 3 | MP:0031468 | |
| MousePheno | abnormal gustatory system morphology | 5.36e-05 | 7 | 164 | 3 | MP:0005500 | |
| Domain | Ig-like_fold | IL10RA CEACAM5 PDGFRB NCAM1 DSCAML1 CD84 MET CEACAM21 PTPRH FCGR2A FCGR3A FCGR3B MYBPHL SDK1 PLXNA1 ADGRA3 HSPG2 SLAMF9 LRRN1 VASN PKHD1L1 LEPR IFNGR1 HMCN1 IGHG1 IGHG3 VCAN PLXNA4 SIGLEC1 | 6.46e-10 | 706 | 202 | 29 | IPR013783 |
| Domain | - | IL10RA CEACAM5 PDGFRB NCAM1 DSCAML1 CD84 MET CEACAM21 FCGR2A FCGR3A FCGR3B MYBPHL SDK1 PLXNA1 ADGRA3 HSPG2 SLAMF9 LRRN1 VASN PKHD1L1 LEPR IFNGR1 HMCN1 VCAN PLXNA4 SIGLEC1 | 1.40e-08 | 663 | 202 | 26 | 2.60.40.10 |
| Domain | IG_LIKE | CEACAM5 PDGFRB NCAM1 DSCAML1 CD84 CEACAM21 FCGR2A FCGR3A FCGR3B MYBPHL SDK1 ADGRA3 HSPG2 SLAMF9 LRRN1 LEPR HMCN1 IGHG1 IGHG3 VCAN SIGLEC1 | 9.04e-08 | 491 | 202 | 21 | PS50835 |
| Domain | Ig-like_dom | CEACAM5 PDGFRB NCAM1 DSCAML1 CD84 CEACAM21 FCGR2A FCGR3A FCGR3B MYBPHL SDK1 ADGRA3 HSPG2 SLAMF9 LRRN1 LEPR HMCN1 IGHG1 IGHG3 VCAN SIGLEC1 | 1.35e-07 | 503 | 202 | 21 | IPR007110 |
| Domain | IG | CEACAM5 PDGFRB NCAM1 DSCAML1 CD84 CEACAM21 FCGR2A FCGR3A FCGR3B MYBPHL SDK1 ADGRA3 HSPG2 SLAMF9 LRRN1 HMCN1 VCAN SIGLEC1 | 7.92e-07 | 421 | 202 | 18 | SM00409 |
| Domain | Ig_sub | CEACAM5 PDGFRB NCAM1 DSCAML1 CD84 CEACAM21 FCGR2A FCGR3A FCGR3B MYBPHL SDK1 ADGRA3 HSPG2 SLAMF9 LRRN1 HMCN1 VCAN SIGLEC1 | 7.92e-07 | 421 | 202 | 18 | IPR003599 |
| Domain | Ig_I-set | CEACAM5 PDGFRB NCAM1 DSCAML1 CEACAM21 MYBPHL SDK1 ADGRA3 HSPG2 LRRN1 HMCN1 SIGLEC1 | 1.11e-06 | 190 | 202 | 12 | IPR013098 |
| Domain | I-set | CEACAM5 PDGFRB NCAM1 DSCAML1 CEACAM21 MYBPHL SDK1 ADGRA3 HSPG2 LRRN1 HMCN1 SIGLEC1 | 1.11e-06 | 190 | 202 | 12 | PF07679 |
| Domain | ig | CEACAM5 PDGFRB NCAM1 DSCAML1 CEACAM21 FCGR2A FCGR3A FCGR3B ADGRA3 HSPG2 HMCN1 SIGLEC1 | 1.11e-06 | 190 | 202 | 12 | PF00047 |
| Domain | Immunoglobulin | CEACAM5 PDGFRB NCAM1 DSCAML1 CEACAM21 FCGR2A FCGR3A FCGR3B ADGRA3 HSPG2 HMCN1 SIGLEC1 | 1.11e-06 | 190 | 202 | 12 | IPR013151 |
| Domain | IGc2 | CEACAM5 PDGFRB NCAM1 DSCAML1 CEACAM21 FCGR2A MYBPHL SDK1 HSPG2 LRRN1 HMCN1 SIGLEC1 | 1.00e-05 | 235 | 202 | 12 | SM00408 |
| Domain | Ig_sub2 | CEACAM5 PDGFRB NCAM1 DSCAML1 CEACAM21 FCGR2A MYBPHL SDK1 HSPG2 LRRN1 HMCN1 SIGLEC1 | 1.00e-05 | 235 | 202 | 12 | IPR003598 |
| Domain | FN3_dom | IL10RA NCAM1 DSCAML1 PTPRH ATF7IP2 MYBPHL SDK1 LRRN1 VASN LEPR IFNGR1 | 1.78e-05 | 209 | 202 | 11 | IPR003961 |
| Domain | - | 1.09e-04 | 44 | 202 | 5 | 3.40.850.10 | |
| Domain | Kinesin | 1.09e-04 | 44 | 202 | 5 | PF00225 | |
| Domain | KISc | 1.09e-04 | 44 | 202 | 5 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 1.09e-04 | 44 | 202 | 5 | PS00411 | |
| Domain | Kinesin_motor_dom | 1.09e-04 | 44 | 202 | 5 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 1.09e-04 | 44 | 202 | 5 | PS50067 | |
| Domain | APPLE | 1.16e-04 | 2 | 202 | 2 | PS00495 | |
| Domain | Apple | 1.16e-04 | 2 | 202 | 2 | IPR000177 | |
| Domain | APPLE | 1.16e-04 | 2 | 202 | 2 | SM00223 | |
| Domain | Ig_2 | 1.38e-04 | 73 | 202 | 6 | PF13895 | |
| Domain | IPT | 1.92e-04 | 27 | 202 | 4 | SM00429 | |
| Domain | FN3 | 3.25e-04 | 199 | 202 | 9 | PS50853 | |
| Domain | TIG | 3.32e-04 | 31 | 202 | 4 | PF01833 | |
| Domain | Period_circadian-like_C | 3.47e-04 | 3 | 202 | 2 | IPR022728 | |
| Domain | Period_C | 3.47e-04 | 3 | 202 | 2 | PF12114 | |
| Domain | IPT | 3.77e-04 | 32 | 202 | 4 | IPR002909 | |
| Domain | Neural_cell_adh | 6.88e-04 | 4 | 202 | 2 | IPR009138 | |
| Domain | PPR | 6.88e-04 | 4 | 202 | 2 | PF01535 | |
| Domain | TF_AF4/FMR2 | 6.88e-04 | 4 | 202 | 2 | IPR007797 | |
| Domain | AF-4 | 6.88e-04 | 4 | 202 | 2 | PF05110 | |
| Domain | LAM_G_DOMAIN | 7.35e-04 | 38 | 202 | 4 | PS50025 | |
| Domain | Laminin_G_2 | 8.95e-04 | 40 | 202 | 4 | PF02210 | |
| Domain | FN3 | 9.31e-04 | 185 | 202 | 8 | SM00060 | |
| Domain | Ig_E-set | 9.36e-04 | 104 | 202 | 6 | IPR014756 | |
| Domain | Kinesin_motor_CS | 9.83e-04 | 41 | 202 | 4 | IPR019821 | |
| Domain | Kinesin-like_fam | 1.18e-03 | 43 | 202 | 4 | IPR027640 | |
| Domain | LamG | 1.29e-03 | 44 | 202 | 4 | SM00282 | |
| Domain | FA58C | 1.44e-03 | 21 | 202 | 3 | SM00231 | |
| Domain | FA58C_3 | 1.44e-03 | 21 | 202 | 3 | PS50022 | |
| Domain | FA58C_1 | 1.44e-03 | 21 | 202 | 3 | PS01285 | |
| Domain | FA58C_2 | 1.44e-03 | 21 | 202 | 3 | PS01286 | |
| Domain | Ig_V-set | 1.48e-03 | 199 | 202 | 8 | IPR013106 | |
| Domain | EGF-like_dom | 1.60e-03 | 249 | 202 | 9 | IPR000742 | |
| Domain | 3Beta_HSD | 1.70e-03 | 6 | 202 | 2 | PF01073 | |
| Domain | 3Beta_OHSteriod_DH/Estase | 1.70e-03 | 6 | 202 | 2 | IPR002225 | |
| Domain | Spectrin | 1.88e-03 | 23 | 202 | 3 | PF00435 | |
| Domain | ACTININ_2 | 1.88e-03 | 23 | 202 | 3 | PS00020 | |
| Domain | ACTININ_1 | 1.88e-03 | 23 | 202 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.88e-03 | 23 | 202 | 3 | IPR001589 | |
| Domain | fn3 | 1.94e-03 | 162 | 202 | 7 | PF00041 | |
| Domain | F5_F8_type_C | 2.13e-03 | 24 | 202 | 3 | PF00754 | |
| Domain | FA58C | 2.13e-03 | 24 | 202 | 3 | IPR000421 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPJ_TO_IGG_FCGR_RAC_SIGNALING_PATHWAY | 1.14e-05 | 5 | 149 | 3 | M49014 | |
| Pathway | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | 1.49e-05 | 15 | 149 | 4 | MM15031 | |
| Pathway | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | 1.98e-05 | 16 | 149 | 4 | M8245 | |
| Pathway | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | 9.28e-05 | 9 | 149 | 3 | MM15030 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGG_FCGR_RAC_SIGNALING_PATHWAY | 1.32e-04 | 10 | 149 | 3 | M47727 | |
| Pathway | REACTOME_FCGR_ACTIVATION | 1.46e-04 | 48 | 149 | 5 | MM17214 | |
| Pathway | REACTOME_SEMAPHORIN_INTERACTIONS | 1.96e-04 | 51 | 149 | 5 | MM14967 | |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | 2.05e-04 | 114 | 149 | 7 | MM14814 | |
| Pubmed | FcγRIV deletion reveals its central role for IgG2a and IgG2b activity in vivo. | 9.23e-10 | 9 | 209 | 5 | 20974962 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DENND4A SETX HIVEP2 ATG13 ANKRD27 GAB2 FSIP2 DST STARD9 SYNE2 KMT2A KIF5B HECTD1 UTRN JCAD DPYSL3 RTCB KIF26B DENND4C VPS13D PLCH1 GEN1 OTOG | 2.81e-09 | 861 | 209 | 23 | 36931259 |
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | GALK1 HIVEP2 EIF4ENIF1 PER2 TACC1 HECTD1 RTCB USP37 DENND4C KIF20A PLCH1 | 1.84e-07 | 232 | 209 | 11 | 25515538 |
| Pubmed | Polymorphism of Fc gamma RIIa may affect the efficacy of gamma-globulin therapy in Kawasaki disease. | 2.14e-07 | 3 | 209 | 3 | 16133986 | |
| Pubmed | 2.14e-07 | 3 | 209 | 3 | 28427365 | ||
| Pubmed | Fcgamma receptor polymorphisms in relation to periodontitis. | 2.14e-07 | 3 | 209 | 3 | 12834496 | |
| Pubmed | 2.14e-07 | 3 | 209 | 3 | 16550341 | ||
| Pubmed | 2.14e-07 | 3 | 209 | 3 | 34551786 | ||
| Pubmed | 2.14e-07 | 3 | 209 | 3 | 18843786 | ||
| Pubmed | Fcgamma receptor IIIA polymorphism as a risk-factor for coronary artery disease. | 2.14e-07 | 3 | 209 | 3 | 15910853 | |
| Pubmed | Fcgamma receptor polymorphisms and their association with periodontal disease: a meta-analysis. | 2.14e-07 | 3 | 209 | 3 | 20149216 | |
| Pubmed | 2.14e-07 | 3 | 209 | 3 | 12710759 | ||
| Pubmed | 2.14e-07 | 3 | 209 | 3 | 21317388 | ||
| Pubmed | Drug-induced agranulocytosis: impact of different fcgamma receptor polymorphisms? | 2.14e-07 | 3 | 209 | 3 | 16160618 | |
| Pubmed | 2.14e-07 | 3 | 209 | 3 | 33424858 | ||
| Pubmed | 2.14e-07 | 3 | 209 | 3 | 17710620 | ||
| Pubmed | 2.14e-07 | 3 | 209 | 3 | 16542359 | ||
| Pubmed | Fcgamma receptor IIIA polymorphism as a risk factor for acute poliomyelitis. | 2.14e-07 | 3 | 209 | 3 | 12447772 | |
| Pubmed | Fc-gamma receptor polymorphisms are not associated with autoimmune Addison's disease. | 2.14e-07 | 3 | 209 | 3 | 17523948 | |
| Pubmed | Fc gamma receptor genes as risk markers for localized aggressive periodontitis in African-Americans. | 2.14e-07 | 3 | 209 | 3 | 12027254 | |
| Pubmed | 2.14e-07 | 3 | 209 | 3 | 11835346 | ||
| Pubmed | 2.14e-07 | 3 | 209 | 3 | 19026120 | ||
| Pubmed | 2.14e-07 | 3 | 209 | 3 | 12064825 | ||
| Pubmed | 2.14e-07 | 3 | 209 | 3 | 12121275 | ||
| Pubmed | Association of the Fc gamma receptor IIA-R/R131 genotype with myasthenia gravis in Dutch patients. | 2.14e-07 | 3 | 209 | 3 | 14597109 | |
| Pubmed | 2.14e-07 | 3 | 209 | 3 | 22167032 | ||
| Pubmed | Polymorphisms of Immunoglobulin G Fc Receptors in Pediatric Guillain-Barré Syndrome. | 2.14e-07 | 3 | 209 | 3 | 27064330 | |
| Pubmed | FCGR2A, FCGR3A, FCGR3B polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis. | 2.14e-07 | 3 | 209 | 3 | 26314337 | |
| Pubmed | 2.14e-07 | 3 | 209 | 3 | 12176802 | ||
| Pubmed | No association of Fc gamma RIIa, Fc gamma RIIIa and Fc gamma RIIIb polymorphisms with MS. | 2.14e-07 | 3 | 209 | 3 | 12864991 | |
| Pubmed | Association of Fcgamma receptor IIa genotype with chronic periodontitis in Caucasians. | 2.14e-07 | 3 | 209 | 3 | 15152814 | |
| Pubmed | The Fc gamma receptor genotype as a severity factor for chronic periodontitis in Japanese patients. | 2.14e-07 | 3 | 209 | 3 | 11699473 | |
| Pubmed | 2.14e-07 | 3 | 209 | 3 | 12501257 | ||
| Pubmed | 2.14e-07 | 3 | 209 | 3 | 11528518 | ||
| Pubmed | 2.14e-07 | 3 | 209 | 3 | 22565545 | ||
| Pubmed | 2.14e-07 | 3 | 209 | 3 | 23649770 | ||
| Pubmed | The role of fcgamma receptor gene polymorphism in pediatric renal transplant rejections. | 2.14e-07 | 3 | 209 | 3 | 19100392 | |
| Pubmed | Severity of Guillain-Barré syndrome is associated with Fc gamma Receptor III polymorphisms. | 2.14e-07 | 3 | 209 | 3 | 15833371 | |
| Pubmed | Fcgamma receptor IIa, IIIa, and IIIb polymorphisms of systemic lupus erythematosus in Taiwan. | 2.14e-07 | 3 | 209 | 3 | 15194589 | |
| Pubmed | INCENP NARS1 PSMD1 NKRF DNTTIP2 TASOR2 DST SYNE2 CPSF1 KMT2A UTP20 KIF5B HECTD1 UTRN RTCB RPSA HELZ2 | 5.18e-07 | 653 | 209 | 17 | 22586326 | |
| Pubmed | DENND4A DST EIF4ENIF1 DDHD2 HECTD1 UTRN KIF26B CIP2A DENND4C VPS13D | 6.18e-07 | 209 | 209 | 10 | 36779422 | |
| Pubmed | 6.56e-07 | 28 | 209 | 5 | 17951031 | ||
| Pubmed | 7.09e-07 | 52 | 209 | 6 | 26633812 | ||
| Pubmed | 8.52e-07 | 4 | 209 | 3 | 22908332 | ||
| Pubmed | 8.52e-07 | 4 | 209 | 3 | 16356189 | ||
| Pubmed | Functional polymorphisms of PTPN22 and FcgR genes in Tunisian patients with rheumatoid arthritis. | 8.52e-07 | 4 | 209 | 3 | 20707220 | |
| Pubmed | Ethnic variation of Fc gamma receptor polymorphism in Sami and Norwegian populations. | 8.52e-07 | 4 | 209 | 3 | 15946259 | |
| Pubmed | 8.52e-07 | 4 | 209 | 3 | 37117756 | ||
| Pubmed | 8.52e-07 | 4 | 209 | 3 | 16520389 | ||
| Pubmed | 8.52e-07 | 4 | 209 | 3 | 14651519 | ||
| Pubmed | Identification of CD16-2, a novel mouse receptor homologous to CD16/Fc gamma RIII. | 8.52e-07 | 4 | 209 | 3 | 12389094 | |
| Pubmed | Relevance of Fcgamma receptor and interleukin-10 polymorphisms for meningococcal disease. | 8.52e-07 | 4 | 209 | 3 | 11740730 | |
| Pubmed | 8.52e-07 | 4 | 209 | 3 | 19640933 | ||
| Pubmed | Organization of the human and mouse low-affinity Fc gamma R genes: duplication and recombination. | 8.52e-07 | 4 | 209 | 3 | 2139735 | |
| Pubmed | IgEb immune complexes activate macrophages through FcgammaRIV binding. | 8.52e-07 | 4 | 209 | 3 | 17558411 | |
| Pubmed | 1.12e-06 | 31 | 209 | 5 | 29099309 | ||
| Pubmed | 1.21e-06 | 14 | 209 | 4 | 21525298 | ||
| Pubmed | A Large-scale genetic association study of esophageal adenocarcinoma risk. | IL10RA NRIP1 PDGFRB BCL6 BRCA2 FCGR2A UMPS HSD3B1 HSD3B2 RB1 LEPR IFNGR1 | 1.65e-06 | 351 | 209 | 12 | 20453000 |
| Pubmed | TCAF1 PER3 ATP11A DDHD2 HECTD1 LRRN1 CIP2A RNF213 USP37 VPS13D THADA HELZ2 PLCH1 UNC80 | 1.99e-06 | 493 | 209 | 14 | 15368895 | |
| Pubmed | Association between SLE nephritis and polymorphic variants of the CRP and FcgammaRIIIa genes. | 2.12e-06 | 5 | 209 | 3 | 17596285 | |
| Pubmed | 2.12e-06 | 5 | 209 | 3 | 19050295 | ||
| Pubmed | 2.12e-06 | 5 | 209 | 3 | 12486608 | ||
| Pubmed | 2.12e-06 | 5 | 209 | 3 | 19309690 | ||
| Pubmed | 2.12e-06 | 5 | 209 | 3 | 25345863 | ||
| Pubmed | Evidence for non-random distribution of Fcgamma receptor genotype combinations. | 2.12e-06 | 5 | 209 | 3 | 12830330 | |
| Pubmed | Murine IgG1 complexes trigger immune effector functions predominantly via Fc gamma RIII (CD16). | 2.12e-06 | 5 | 209 | 3 | 9743367 | |
| Pubmed | 2.12e-06 | 5 | 209 | 3 | 9834201 | ||
| Pubmed | 2.12e-06 | 5 | 209 | 3 | 18372357 | ||
| Pubmed | 2.12e-06 | 5 | 209 | 3 | 36779803 | ||
| Pubmed | 2.12e-06 | 5 | 209 | 3 | 20439936 | ||
| Pubmed | Copy number, linkage disequilibrium and disease association in the FCGR locus. | 2.12e-06 | 5 | 209 | 3 | 20508037 | |
| Pubmed | The Noncanonical Role of ULK/ATG1 in ER-to-Golgi Trafficking Is Essential for Cellular Homeostasis. | 2.12e-06 | 5 | 209 | 3 | 27203176 | |
| Pubmed | 2.18e-06 | 16 | 209 | 4 | 16517735 | ||
| Pubmed | 4.22e-06 | 6 | 209 | 3 | 23897981 | ||
| Pubmed | 4.22e-06 | 6 | 209 | 3 | 21832933 | ||
| Pubmed | 4.22e-06 | 6 | 209 | 3 | 18495955 | ||
| Pubmed | B cell-intrinsic CD84 and Ly108 maintain germinal center B cell tolerance. | 4.22e-06 | 6 | 209 | 3 | 25801429 | |
| Pubmed | 4.22e-06 | 6 | 209 | 3 | 22430937 | ||
| Pubmed | 4.22e-06 | 6 | 209 | 3 | 18052703 | ||
| Pubmed | 4.22e-06 | 6 | 209 | 3 | 27769169 | ||
| Pubmed | 4.22e-06 | 6 | 209 | 3 | 17335370 | ||
| Pubmed | 4.22e-06 | 6 | 209 | 3 | 22502635 | ||
| Pubmed | 4.22e-06 | 6 | 209 | 3 | 16110781 | ||
| Pubmed | 6.65e-06 | 162 | 209 | 8 | 25826454 | ||
| Pubmed | 7.36e-06 | 7 | 209 | 3 | 18209093 | ||
| Pubmed | Increased proximal bifurcation of CA1 pyramidal apical dendrites in sema3A mutant mice. | 7.36e-06 | 7 | 209 | 3 | 19655386 | |
| Pubmed | 7.36e-06 | 7 | 209 | 3 | 18322226 | ||
| Pubmed | 7.36e-06 | 7 | 209 | 3 | 15100265 | ||
| Pubmed | IgG-Immune Complexes Promote B Cell Memory by Inducing BAFF. | 7.36e-06 | 7 | 209 | 3 | 26621863 | |
| Pubmed | Cartilage-binding antibodies induce pain through immune complex-mediated activation of neurons. | 7.36e-06 | 7 | 209 | 3 | 31196979 | |
| Pubmed | FcgammaRIV: a novel FcR with distinct IgG subclass specificity. | 7.36e-06 | 7 | 209 | 3 | 16039578 | |
| Pubmed | Co-inhibition of CD73 and A2AR Adenosine Signaling Improves Anti-tumor Immune Responses. | 7.36e-06 | 7 | 209 | 3 | 27622332 | |
| Pubmed | 7.36e-06 | 7 | 209 | 3 | 23850379 | ||
| Pubmed | 7.36e-06 | 7 | 209 | 3 | 23754379 | ||
| Pubmed | 7.36e-06 | 7 | 209 | 3 | 32195245 | ||
| Pubmed | Bim establishes the B-cell repertoire from early to late in the immune response. | 7.36e-06 | 7 | 209 | 3 | 32889526 | |
| Pubmed | DC subset-specific induction of T cell responses upon antigen uptake via Fcγ receptors in vivo. | 7.36e-06 | 7 | 209 | 3 | 28389502 | |
| Pubmed | 7.36e-06 | 7 | 209 | 3 | 24412922 | ||
| Pubmed | Elongator and codon bias regulate protein levels in mammalian peripheral neurons. | 7.36e-06 | 7 | 209 | 3 | 29497044 | |
| Pubmed | 7.36e-06 | 7 | 209 | 3 | 18097064 | ||
| Cytoband | 1q23 | 1.54e-04 | 23 | 209 | 3 | 1q23 | |
| Cytoband | 6q24 | 5.67e-04 | 8 | 209 | 2 | 6q24 | |
| Cytoband | 11q23 | 5.94e-04 | 36 | 209 | 3 | 11q23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q23 | 6.25e-04 | 226 | 209 | 6 | chr1q23 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | CEACAM5 PDGFRB NCAM1 DSCAML1 MYBPHL SDK1 ADGRA3 HSPG2 LRRN1 HMCN1 SIGLEC1 | 5.00e-08 | 161 | 140 | 11 | 593 |
| GeneFamily | Immunoglobulin like domain containing | CEACAM5 PDGFRB DSCAML1 CD84 CEACAM21 FCGR2A FCGR3A FCGR3B SDK1 HSPG2 LEPR | 3.16e-07 | 193 | 140 | 11 | 594 |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 2.75e-05 | 46 | 140 | 5 | 622 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | IL10RA CEACAM5 PDGFRB NCAM1 NRP1 CD84 FCGR2A FCGR3A FCGR3B LEPR IFNGR1 SIGLEC1 | 5.76e-05 | 394 | 140 | 12 | 471 |
| GeneFamily | UPF1 like RNA helicases | 7.16e-05 | 11 | 140 | 3 | 1169 | |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 3.54e-04 | 4 | 140 | 2 | 1145 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 4.02e-04 | 19 | 140 | 3 | 832 | |
| GeneFamily | Fibronectin type III domain containing | 1.55e-03 | 160 | 140 | 6 | 555 | |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 2.07e-03 | 9 | 140 | 2 | 1280 | |
| GeneFamily | Plexins | 2.07e-03 | 9 | 140 | 2 | 683 | |
| GeneFamily | Autophagy related | 2.09e-03 | 33 | 140 | 3 | 1022 | |
| GeneFamily | Phospholipases | 4.18e-03 | 42 | 140 | 3 | 467 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 4.47e-03 | 43 | 140 | 3 | 409 | |
| GeneFamily | Kallikreins | 6.65e-03 | 16 | 140 | 2 | 616 | |
| GeneFamily | Potassium voltage-gated channel subfamily J | 6.65e-03 | 16 | 140 | 2 | 276 | |
| Coexpression | GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_DN | NRIP1 SAMD9 KLHDC7B BRCA2 KIAA1958 RTCB POLE2 RNF213 ZNFX1 HELZ2 SIGLEC1 | 5.73e-07 | 198 | 208 | 11 | M3302 |
| Coexpression | GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_MYELOID_UP | IL16 HIVEP2 BACH2 SIDT1 SLC38A1 SYNE2 ATF7IP2 RPSA NOSIP BCL11B | 4.63e-06 | 199 | 208 | 10 | M3087 |
| Coexpression | ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN | 1.22e-05 | 38 | 208 | 5 | M1751 | |
| Coexpression | MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP | 1.59e-05 | 182 | 208 | 9 | MM993 | |
| Coexpression | FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN | NRIP1 TCAF1 SETX SAMD9 BCL6 GAB2 CD84 FCGR3A FCGR3B AFF1 RB1 RNF213 CHFR SIGLEC1 | 1.94e-05 | 458 | 208 | 14 | M4785 |
| Coexpression | ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN | 2.01e-05 | 42 | 208 | 5 | MM733 | |
| Coexpression | GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_UP | 3.34e-05 | 200 | 208 | 9 | M7417 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_top-relative-expression-ranked_100 | 2.24e-06 | 63 | 202 | 7 | gudmap_kidney_P0_CapMes_Crym_100 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k-means-cluster#1_top-relative-expression-ranked_200 | 1.09e-05 | 53 | 202 | 6 | gudmap_dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k1_200 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_top-relative-expression-ranked_100 | 1.55e-05 | 84 | 202 | 7 | gudmap_kidney_P2_CapMes_Crym_100 | |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_top-relative-expression-ranked_200 | 1.97e-05 | 120 | 202 | 8 | gudmap_kidney_P1_CapMes_Crym_200 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_top-relative-expression-ranked_200 | 2.50e-05 | 124 | 202 | 8 | gudmap_kidney_P0_CapMes_Crym_200 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#1_top-relative-expression-ranked_500 | 2.65e-05 | 125 | 202 | 8 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k1_500 | |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_top-relative-expression-ranked_100 | 2.72e-05 | 62 | 202 | 6 | gudmap_kidney_P1_CapMes_Crym_100 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_top-relative-expression-ranked_200 | 5.67e-05 | 139 | 202 | 8 | gudmap_kidney_P2_CapMes_Crym_200 | |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_top-relative-expression-ranked_500 | NCAM1 GFRA1 SLC38A1 MET HOXC8 DST LRRN1 KIF26B HMCN1 VCAN PLCH1 | 7.13e-05 | 276 | 202 | 11 | gudmap_kidney_P1_CapMes_Crym_500 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_100 | 8.60e-05 | 25 | 202 | 4 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_100 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_top-relative-expression-ranked_500 | NCAM1 PSMD5 GFRA1 MET HOXC8 DST LRRN1 KIF26B HMCN1 VCAN PLCH1 | 1.25e-04 | 294 | 202 | 11 | gudmap_kidney_P0_CapMes_Crym_500 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_200 | 1.58e-04 | 161 | 202 | 8 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000 | DENND4A BACH2 LRRTM3 BCL6 TASOR2 DST STARD9 SYNE2 ADGRA3 DPYSL3 LRRN1 KIF26B CIP2A PCDH20 LEPR BCL11B ALX1 HMCN1 VCAN ZNF385C | 1.86e-04 | 850 | 202 | 20 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_200 | 1.95e-04 | 166 | 202 | 8 | gudmap_kidney_P3_CapMes_Crym_200 | |
| CoexpressionAtlas | dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.97e-04 | 211 | 202 | 9 | gudmap_dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_k2_1000 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.34e-04 | 91 | 202 | 6 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k2_1000 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CSMD3 DSCAML1 SDK1 ZAN KIF26B GRM1 PKHD1L1 DNAH1 HMCN1 PLCH1 UNC80 OTOG PLCE1 | 4.63e-12 | 184 | 209 | 13 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CSMD3 DSCAML1 SDK1 ZAN KIF26B GRM1 PKHD1L1 DNAH1 HMCN1 PLCH1 UNC80 OTOG PLCE1 | 4.63e-12 | 184 | 209 | 13 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CSMD3 DSCAML1 SDK1 ZAN KIF26B GRM1 PKHD1L1 DNAH1 HMCN1 PLCH1 UNC80 OTOG PLCE1 | 4.63e-12 | 184 | 209 | 13 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | MYT1 CSMD3 CNTNAP5 KLKB1 ZAN CIP2A KPRP PKD2L1 PKHD1L1 SIGLEC1 UNC80 | 3.23e-10 | 162 | 209 | 11 | bf886e22ff2a20353499004b53f25fb9e6574896 |
| ToppCell | Control-B_intermediate-10|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | MYT1 CD84 SLC38A1 FCGR2A P2RY12 VASN NT5C3B BCL11B IGHG1 IGHG3 GEN1 | 1.96e-09 | 192 | 209 | 11 | 224bd958369ba8fa0d7be2126f7dc61c9f6ac19d |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | SETX SAMD9 PDGFRB NCAM1 FCGR3A FCGR3B SYNE2 DTHD1 UTRN RNF213 NBPF10 | 3.01e-09 | 200 | 209 | 11 | 2281debd86e5d92e8fe0397aec9ef670800f7471 |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | HIVEP2 CSMD3 AEBP1 KLKB1 ZAN PKHD1L1 DNAH1 PLXNA4 PLCH1 UNC80 | 7.92e-09 | 169 | 209 | 10 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 |
| ToppCell | control-Myeloid-Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | SAMD9 BCL6 FCGR2A FCGR3A FCGR3B KCNJ15 RNF213 ZNFX1 HELZ2 SIGLEC1 | 2.95e-08 | 194 | 209 | 10 | 267e213e8efe53aadfe553a2ca010a0e3b4b8939 |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | SETX INCENP PDGFRB SIDT1 SLC38A1 FCGR3A FCGR3B SYNE2 UTRN RNF213 | 3.58e-08 | 198 | 209 | 10 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.93e-08 | 200 | 209 | 10 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.93e-08 | 200 | 209 | 10 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.93e-08 | 200 | 209 | 10 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.93e-08 | 200 | 209 | 10 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.93e-08 | 200 | 209 | 10 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.82e-07 | 179 | 209 | 9 | e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.91e-07 | 180 | 209 | 9 | 6a2366d76276452141db1bd93013a9503525f574 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.75e-07 | 188 | 209 | 9 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | LV-14._Fibroblast_III|World / Chamber and Cluster_Paper | 2.88e-07 | 189 | 209 | 9 | 3922135d1f6fc768d71ba3b465585fead6ea68a8 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 3.44e-07 | 193 | 209 | 9 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | LV-14._Fibroblast_III|LV / Chamber and Cluster_Paper | 3.59e-07 | 194 | 209 | 9 | 927c26aea0147f7a4b8fb3f192de4de263f1b978 | |
| ToppCell | T_cells-GZMK+_T_cells|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.75e-07 | 195 | 209 | 9 | 003ea7ddec6c1c98d2f6470bb51ebd97450eb936 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.75e-07 | 195 | 209 | 9 | 22191d361af136942508f1553ff41a626ed982ad | |
| ToppCell | control-Myeloid-Neutrophils_2|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.08e-07 | 197 | 209 | 9 | 8819db1550bf14566c6d33d97f7f83419e867ace | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.08e-07 | 197 | 209 | 9 | e42910a653a1b5bd90c090e9665a84871ed2873f | |
| ToppCell | COVID-19_Severe-NK_activated|World / disease group, cell group and cell class | 4.08e-07 | 197 | 209 | 9 | a60db36d1a192998e3ded63e0c7c08d41689f95f | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 4.26e-07 | 198 | 209 | 9 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.26e-07 | 198 | 209 | 9 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | Epithelial_cells-AT1-AT2_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 4.26e-07 | 198 | 209 | 9 | fbc46b20bcd44f2083170aacbc6f5dd00fba685c | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC-NK_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.44e-07 | 199 | 209 | 9 | ed35d747f11f6ea6a5cb7061057f0a98d9e0db99 | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | 4.44e-07 | 199 | 209 | 9 | 952fac67588ad5676f5939e3c7f8bac803c27064 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.44e-07 | 199 | 209 | 9 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-SPP1+_Mac|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.44e-07 | 199 | 209 | 9 | 7c19f1b1f4369edd035ca9cdcf4e653771fc4648 | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.44e-07 | 199 | 209 | 9 | df4f7d5be099e3e6054f3b812ccf70251664e4c0 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-dn_T|COVID-19_Mild / Disease, condition lineage and cell class | 4.44e-07 | 199 | 209 | 9 | f307d4887b28cf60a591439e278fd668409cb104 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-dn_T|Control / Disease, condition lineage and cell class | 4.63e-07 | 200 | 209 | 9 | 10882c59b7aaf8bd4b5c00aa4ddbb9f7ac5b2cf5 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.63e-07 | 200 | 209 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class | 4.63e-07 | 200 | 209 | 9 | d9e8a0d047d4403fb7265fde7448e23a7780785c | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.63e-07 | 200 | 209 | 9 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.63e-07 | 200 | 209 | 9 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | mild-NK|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.63e-07 | 200 | 209 | 9 | a11fb1d7e124c352eb73fea0e0ec0fed577c97f7 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.63e-07 | 200 | 209 | 9 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | severe_COVID-19-pDC|World / disease group, cell group and cell class (v2) | 8.81e-07 | 159 | 209 | 8 | e1c48c4ceda116826819ff9adeed7bad6a58844d | |
| ToppCell | facs-Pancreas-Endocrine-3m-Hematologic|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-06 | 165 | 209 | 8 | 4d51eb992670bce164eea29b540877b4d567953c | |
| ToppCell | facs-Pancreas-Endocrine-3m-Hematologic-leukocyte|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-06 | 165 | 209 | 8 | 2e9e703c3f89784a47ed40f799d2aa86eba6cc9a | |
| ToppCell | facs-Pancreas-Endocrine-3m-Hematologic-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-06 | 165 | 209 | 8 | 8715ea74d02e9b7cd05fa1b4896b353078544678 | |
| ToppCell | Thalamus-Hematopoietic|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.22e-06 | 166 | 209 | 8 | 76d60ac7ac5d1eaf530f0c741d9c48e0bd58396b | |
| ToppCell | Healthy_Control-Lymphoid-pDC|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.39e-06 | 169 | 209 | 8 | a4e9b8b2f0338203455ba941b8f99bf4884d26f0 | |
| ToppCell | Healthy_Control-Lymphoid-pDC-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.39e-06 | 169 | 209 | 8 | 338ce99897cb522b86edd603f75bc15ec4dfcda3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-06 | 170 | 209 | 8 | 28fb192b21cdc5a77ba4f276694cff852eb2304b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-06 | 170 | 209 | 8 | 239cb4b801b2d71a6facb386f2684c0851504151 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.52e-06 | 171 | 209 | 8 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.59e-06 | 172 | 209 | 8 | f0e767a20d93e546ce278db67dbd779cc68af533 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.74e-06 | 174 | 209 | 8 | d5c22b43531414951666ee7542a66ed9380e2d14 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.74e-06 | 174 | 209 | 8 | f520b79d277e286c9bb5d091e6c94e7ec7e46699 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.81e-06 | 175 | 209 | 8 | 876cea684faf42ff3eb4623ad6d7a1fb1276ee02 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-CX3CR1+_CD8_Tmem|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.89e-06 | 176 | 209 | 8 | 6b06da40eb97ea2db09f3a769494738b3e5fe3fa | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.97e-06 | 177 | 209 | 8 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.06e-06 | 178 | 209 | 8 | c77a1d1a9aef0ab51b4408b9e84f201219788ca2 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-06 | 181 | 209 | 8 | 4ea02344e1996f264dd5e14f3b19c8782ce41699 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.43e-06 | 182 | 209 | 8 | 336cd05e46a741185ce3c59ee67a4b07fa6a5101 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.63e-06 | 184 | 209 | 8 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.63e-06 | 184 | 209 | 8 | d2bf0135eb56bb410997dccea39c5ede88a0617f | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.63e-06 | 184 | 209 | 8 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-06 | 185 | 209 | 8 | ca69499ba8c39b7ed6717d05685d6f70066a77bd | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-06 | 185 | 209 | 8 | 38486b69c48dc5e1c4e1488208fa8954a973eccb | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-06 | 185 | 209 | 8 | 3c28b5ceba3cfdb6f7e32d5b42e03b6a81a7a658 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-06 | 186 | 209 | 8 | 9feef5936985e936b3d88f9d1bb012abb6468570 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.85e-06 | 186 | 209 | 8 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-06 | 186 | 209 | 8 | 89f5b06bc56674af304912d481ac697c7c870904 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_dim-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.97e-06 | 187 | 209 | 8 | 0bca79cea4886b66350c56c61859bd71e1e7a85c | |
| ToppCell | Monocytes-M2-like_CD16+_macrophages|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis | 2.97e-06 | 187 | 209 | 8 | 59e31c51183ed4c9a3d0792c8005ea3a12b28dfa | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.97e-06 | 187 | 209 | 8 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | COVID-19_Mild-pDC|COVID-19_Mild / Disease condition and Cell class | 3.09e-06 | 188 | 209 | 8 | 62d33d2990d4a2d32bd0863147e47f656df1966e | |
| ToppCell | COVID-19_Mild-pDC-|COVID-19_Mild / Disease condition and Cell class | 3.09e-06 | 188 | 209 | 8 | a75c2cf2f8dae343c13aaa66b637658b935ed10a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.21e-06 | 189 | 209 | 8 | 28b502611829e4a24caff2562545c7db97686099 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.21e-06 | 189 | 209 | 8 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Mac-Erythrophagocytic_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 3.34e-06 | 190 | 209 | 8 | 96c6078619e85f630c9754aca5d6066433e22836 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.34e-06 | 190 | 209 | 8 | d153a0bdedcd6865e6ee19575234a78b5d859ff1 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.47e-06 | 191 | 209 | 8 | da4062a0f6d0af6d330acf11da216c64b0fa7c73 | |
| ToppCell | Control-B_intermediate-14|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.47e-06 | 191 | 209 | 8 | 076302fd247aab6c0b187ac9e0c67a3ba46414ba | |
| ToppCell | Control-B_intermediate-14|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.47e-06 | 191 | 209 | 8 | 33fce8e086601e636e8c6ef2ab58fcfdd52af369 | |
| ToppCell | RV-08._Macrophage|World / Chamber and Cluster_Paper | 3.61e-06 | 192 | 209 | 8 | a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.61e-06 | 192 | 209 | 8 | ed1fb700d3e8f00495727d61e164fc0b70274fd0 | |
| ToppCell | control-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.75e-06 | 193 | 209 | 8 | 89d407a88b5956559a589425b89b3eb8dc78e1dd | |
| ToppCell | CF-Lymphoid|CF / Disease state, Lineage and Cell class | 3.75e-06 | 193 | 209 | 8 | 11de07d13a7da223990b56fa89ba7fc1c3dd0122 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)|Adult / Lineage, Cell type, age group and donor | 3.75e-06 | 193 | 209 | 8 | 31c0978ba78c9516d498aec0798902e57555e557 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.89e-06 | 194 | 209 | 8 | 96f16bcd393a0d3f8df479b172b5360ae5a1e663 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.89e-06 | 194 | 209 | 8 | 4d7fc4d0a55abb3b645116d13a983bbedc55f70c | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular-Interstitial_macrophage_perivascular_L.1.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.89e-06 | 194 | 209 | 8 | 7b6a34d1f8922b71dcc931421666c1822cec8345 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.89e-06 | 194 | 209 | 8 | 435406ebe626c702f7d5a99a3d68ee85aa09be95 | |
| ToppCell | critical-Myeloid-Monocyte-derived_Macrophage|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.89e-06 | 194 | 209 | 8 | e36d1fd141bdcbd9ed66a33de6cdfde77189a0c1 | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.89e-06 | 194 | 209 | 8 | 3d6f2d190dd50804afea299957cc44c2bb756134 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.89e-06 | 194 | 209 | 8 | 48c37251518f96524807b5bd1bbc2820637666ad | |
| ToppCell | facs-Skin-Telogen-3m|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.89e-06 | 194 | 209 | 8 | ba10fc5929649bb994c3f1d2ce6ca3167fa9b11b | |
| ToppCell | facs-Skin-Telogen|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.89e-06 | 194 | 209 | 8 | bafecab8d48fc94ffd93f0d054b5f32c04b6b3f6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.89e-06 | 194 | 209 | 8 | 45708cb2cafde10bf4e4798b81d47c3b1f6aaa14 | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|lung / Disease (COVID-19 only), tissue and cell type | 4.04e-06 | 195 | 209 | 8 | 148fff8c3c9ba45ec36e98dff1be57e3f8294506 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.04e-06 | 195 | 209 | 8 | 42bfdff88da1d07828c0ad65d412fb1752f0cee4 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.04e-06 | 195 | 209 | 8 | 609732e83ab7fc3ba7dace66f5a17e46557fd6d1 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.04e-06 | 195 | 209 | 8 | ed5f772c82d4dfd1c8735224446ec9feae3fb8c2 | |
| Drug | benzyl-EDTA | 1.34e-06 | 10 | 207 | 4 | CID000129213 | |
| Drug | AC1L201C | 2.08e-06 | 11 | 207 | 4 | CID000012643 | |
| Drug | 3,5-diaminocyclohexan-1-ol | 2.54e-06 | 67 | 207 | 7 | CID004632239 | |
| Drug | AC1L9LMC | 1.07e-05 | 83 | 207 | 7 | CID000448113 | |
| Drug | (1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Up 200; 11.8uM; MCF7; HT_HG-U133A | IL10RA MYO9B HLCS KMT2A STK24 COL4A6 RB1 IKZF4 VPS13D SIGLEC1 | 1.31e-05 | 196 | 207 | 10 | 6053_UP |
| Drug | TAN-1030A | 1.45e-05 | 6 | 207 | 3 | CID009576886 | |
| Drug | ferricrocin iron | 1.77e-05 | 36 | 207 | 5 | CID005288201 | |
| Disease | Malignant neoplasm of breast | NRIP1 XIRP1 ESRRA APC2 HLCS NME8 CDH20 PER3 PER2 BRCA2 SYNE2 KCNJ15 HRG AFF1 UMPS UTP20 KLK15 RB1 JAKMIP3 MCOLN1 PCDH20 LEPR ABCB10 TNS1 GEN1 | 1.13e-07 | 1074 | 203 | 25 | C0006142 |
| Disease | basophil percentage of leukocytes | BCL6 BPI FCGR2A FCGR3A FCGR3B KCNJ15 AFF1 DTHD1 STK25 AFF2 PKD2L1 RPSA | 1.36e-07 | 243 | 203 | 12 | EFO_0007992 |
| Disease | basophil count | BACH2 BCL6 SLC38A1 BPI FCGR2A FCGR3A FCGR3B KCNJ15 AFF1 AFF2 PKD2L1 RPSA ELOF1 LEPR HELZ2 PLCE1 | 2.73e-07 | 483 | 203 | 16 | EFO_0005090 |
| Disease | low affinity immunoglobulin gamma Fc region receptor II-a/b measurement | 1.10e-05 | 7 | 203 | 3 | EFO_0008211 | |
| Disease | level of low affinity immunoglobulin gamma Fc region receptor III-A in blood serum | 4.71e-05 | 2 | 203 | 2 | OBA_2040305 | |
| Disease | neural cell adhesion molecule 1 measurement | 4.71e-05 | 2 | 203 | 2 | EFO_0801826 | |
| Disease | insulin growth factor-like family member 4 measurement | 4.71e-05 | 2 | 203 | 2 | EFO_0801701 | |
| Disease | cerebral cavernous malformation (implicated_via_orthology) | 5.08e-05 | 11 | 203 | 3 | DOID:0060669 (implicated_via_orthology) | |
| Disease | cerebrospinal fluid biomarker measurement | 5.46e-05 | 96 | 203 | 6 | EFO_0006794 | |
| Disease | gastroesophageal reflux disease | 7.25e-05 | 101 | 203 | 6 | EFO_0003948 | |
| Disease | cortical thickness | SIDT1 NCAM1 NRP1 CDH20 KMT2A AFF1 TACC1 KIF5B HSPG2 RPSA VPS13D THADA BCL11B ALX1 KANSL1 VCAN PLCH1 TNS1 ULK2 PLCE1 | 9.24e-05 | 1113 | 203 | 20 | EFO_0004840 |
| Disease | thrombosis (is_implicated_in) | 1.37e-04 | 15 | 203 | 3 | DOID:0060903 (is_implicated_in) | |
| Disease | Lupus Vasculitis, Central Nervous System | 1.41e-04 | 3 | 203 | 2 | C0752332 | |
| Disease | Lupus Meningoencephalitis | 1.41e-04 | 3 | 203 | 2 | C0752334 | |
| Disease | Neuropsychiatric Systemic Lupus Erythematosus | 1.41e-04 | 3 | 203 | 2 | C0752335 | |
| Disease | ameloblastin measurement | 1.41e-04 | 3 | 203 | 2 | EFO_0801377 | |
| Disease | paired immunoglobulin-like type 2 receptor alpha measurement | 1.41e-04 | 3 | 203 | 2 | EFO_0801866 | |
| Disease | prostate-specific antigen measurement | 1.41e-04 | 3 | 203 | 2 | EFO_0020660 | |
| Disease | lymphopenia (is_implicated_in) | 1.41e-04 | 3 | 203 | 2 | DOID:614 (is_implicated_in) | |
| Disease | Advanced Sleep-Phase Syndrome, Familial | 1.41e-04 | 3 | 203 | 2 | C1858496 | |
| Disease | secretoglobin family 1C member 1 measurement | 1.41e-04 | 3 | 203 | 2 | EFO_0802041 | |
| Disease | cortical surface area measurement | SAMD9 MYO9B ATG13 MYT1 SIDT1 NCAM1 NRP1 SLC38A1 USP38 AFF1 TACC1 DPYSL3 ZAN KIF26B RPSA NOSIP THADA BCL11B KANSL1 VCAN TNS1 PLCE1 | 1.58e-04 | 1345 | 203 | 22 | EFO_0010736 |
| Disease | low affinity immunoglobulin gamma Fc region receptor II-a measurement | 2.03e-04 | 17 | 203 | 3 | EFO_0021969 | |
| Disease | hemoglobin A1 measurement | MYO9B MYT1 ANKRD27 GAB2 PTPRH SYNE2 ATP11A PKD2L1 ELOF1 THADA ABCB10 CHFR | 2.78e-04 | 520 | 203 | 12 | EFO_0007629 |
| Disease | di-N-acetylchitobiase measurement | 2.80e-04 | 4 | 203 | 2 | EFO_0801524 | |
| Disease | latent autoimmune diabetes in adults | 2.80e-04 | 4 | 203 | 2 | EFO_0009706 | |
| Disease | advanced sleep phase syndrome (is_implicated_in) | 2.80e-04 | 4 | 203 | 2 | DOID:0050628 (is_implicated_in) | |
| Disease | trem-like transcript 4 protein measurement | 2.80e-04 | 4 | 203 | 2 | EFO_0802160 | |
| Disease | sodium/potassium-transporting ATPase subunit alpha-1 measurement | 2.80e-04 | 4 | 203 | 2 | EFO_0802077 | |
| Disease | RING finger protein 165 measurement | 2.80e-04 | 4 | 203 | 2 | EFO_0802027 | |
| Disease | Osteosarcoma | 3.08e-04 | 47 | 203 | 4 | C0029463 | |
| Disease | monocyte count | NRIP1 DENND4A PDGFRB KLHDC7B BCL6 CD84 BPI PTPRH FCGR3A FCGR3B KCNJ15 DTHD1 JCAD AFF2 PKD2L1 LCT LEPR THADA PPP4R2 VCAN PLCE1 | 3.25e-04 | 1320 | 203 | 21 | EFO_0005091 |
| Disease | cardiovascular disease | TDRD15 HIVEP2 MYO9B RTKN2 PRDM8 USP38 ATG7 PKD2L1 THADA BCL11B PLCE1 | 3.51e-04 | 457 | 203 | 11 | EFO_0000319 |
| Disease | bactericidal permeability-increasing protein measurement | 4.65e-04 | 5 | 203 | 2 | EFO_0020172 | |
| Disease | potassium voltage-gated channel subfamily E member 2 measurement | 4.65e-04 | 5 | 203 | 2 | EFO_0801901 | |
| Disease | protein shisa-3 homolog measurement | 4.65e-04 | 5 | 203 | 2 | EFO_0801964 | |
| Disease | YKL40 measurement, cerebrospinal fluid biomarker measurement | 4.65e-04 | 5 | 203 | 2 | EFO_0004869, EFO_0006794 | |
| Disease | Neoplasm of the genitourinary tract | 5.84e-04 | 24 | 203 | 3 | cv:C0042065 | |
| Disease | partial thromboplastin time | 5.84e-04 | 24 | 203 | 3 | EFO_0004310 | |
| Disease | triglycerides in LDL measurement | 6.04e-04 | 56 | 203 | 4 | EFO_0022320 | |
| Disease | low affinity immunoglobulin gamma Fc region receptor II-b measurement | 6.60e-04 | 25 | 203 | 3 | EFO_0021970 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 6.87e-04 | 153 | 203 | 6 | EFO_0004611, EFO_0020946 | |
| Disease | carcinoembryonic antigen-related cell adhesion molecule 1 measurement | 6.94e-04 | 6 | 203 | 2 | EFO_0801456 | |
| Disease | beta-sarcoglycan measurement | 6.94e-04 | 6 | 203 | 2 | EFO_0801422 | |
| Disease | multiple coagulation factor deficiency protein 2 measurement | 6.94e-04 | 6 | 203 | 2 | EFO_0801810 | |
| Disease | complement C1q subcomponent measurement | 6.94e-04 | 6 | 203 | 2 | EFO_0008089 | |
| Disease | lipopolysaccharide-binding protein measurement | 6.94e-04 | 6 | 203 | 2 | EFO_0021894 | |
| Disease | mean arterial pressure | MYO9B HLCS NCAM1 PRDM8 ATG7 PKD2L1 RNF213 IKZF4 THADA TNS1 PLCE1 | 7.26e-04 | 499 | 203 | 11 | EFO_0006340 |
| Disease | apolipoprotein B measurement | TDRD15 GALK1 SLC38A1 PRDM8 BRCA2 SYNE2 AFF1 EPS8L3 MYBPHL KLKB1 PKD2L1 THADA RFLNA | 7.29e-04 | 663 | 203 | 13 | EFO_0004615 |
| Disease | cerebellum cortex volume change measurement, age at assessment | 7.42e-04 | 26 | 203 | 3 | EFO_0008007, EFO_0021497 | |
| Disease | Thyroid preparation use measurement | 7.95e-04 | 217 | 203 | 7 | EFO_0009933 | |
| Disease | Alzheimer disease, polygenic risk score | ATG13 PLPPR3 ABCA7 NRP1 FSIP2 DST STK24 SDK1 ZAN OR5V1 KANSL1 PLCH1 | 8.00e-04 | 586 | 203 | 12 | EFO_0030082, MONDO_0004975 |
| Disease | fatty acid measurement | TDRD15 INCENP DSCAML1 SLC38A1 KMT2A AFF1 PKD2L1 KANSL1 PLXNA4 RFLNA | 9.35e-04 | 436 | 203 | 10 | EFO_0005110 |
| Disease | reticulocyte count | DENND4A MYO9B PLPPR3 NRP1 CDH20 PTPRH SYNE2 MAPKAPK3 ATP11A SPATA20 USP37 THADA KANSL1 DCAF10 RFLNA ZNF385C TNS1 | 9.55e-04 | 1045 | 203 | 17 | EFO_0007986 |
| Disease | Early Pregnancy Loss | 9.60e-04 | 109 | 203 | 5 | C3830362 | |
| Disease | Spontaneous abortion | 9.60e-04 | 109 | 203 | 5 | C0000786 | |
| Disease | Miscarriage | 9.60e-04 | 109 | 203 | 5 | C4552766 | |
| Disease | Abortion, Tubal | 9.60e-04 | 109 | 203 | 5 | C0000822 | |
| Disease | Urogenital Abnormalities | 9.67e-04 | 7 | 203 | 2 | C0042063 | |
| Disease | age at diagnosis, osteoarthritis | 9.67e-04 | 7 | 203 | 2 | EFO_0004918, MONDO_0005178 | |
| Disease | anxiety, smoking behaviour measurement | 9.67e-04 | 7 | 203 | 2 | EFO_0005230, EFO_0005671 | |
| Disease | SLAM family member 5 measurement | 9.67e-04 | 7 | 203 | 2 | EFO_0020741 | |
| Disease | inducible T-cell costimulator measurement | 9.67e-04 | 7 | 203 | 2 | EFO_0021967 | |
| Disease | leucine-rich PPR motif-containing protein, mitochondrial measurement | 9.67e-04 | 7 | 203 | 2 | EFO_0801758 | |
| Disease | respiratory failure, COVID-19 | 1.03e-03 | 29 | 203 | 3 | EFO_0009686, MONDO_0100096 | |
| Disease | arteriosclerosis (is_marker_for) | 1.03e-03 | 29 | 203 | 3 | DOID:2349 (is_marker_for) | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 1.05e-03 | 166 | 203 | 6 | EFO_0004530, EFO_0004611 | |
| Disease | Crohn's disease (is_implicated_in) | 1.14e-03 | 30 | 203 | 3 | DOID:8778 (is_implicated_in) | |
| Disease | squamous cell carcinoma | 1.19e-03 | 67 | 203 | 4 | EFO_0000707 | |
| Disease | neuroimaging measurement | SAMD9 PSMD1 NRP1 TYK2 AFF1 UMPS DPYSL3 KIF26B RPSA DENND4C THADA BCL11B KANSL1 VCAN PLCH1 TNS1 PLCE1 | 1.22e-03 | 1069 | 203 | 17 | EFO_0004346 |
| Disease | factor XI measurement, coronary artery disease | 1.22e-03 | 115 | 203 | 5 | EFO_0001645, EFO_0004694 | |
| Disease | ceramide measurement | 1.26e-03 | 235 | 203 | 7 | EFO_0010222 | |
| Disease | factor XI measurement | 1.28e-03 | 8 | 203 | 2 | EFO_0004694 | |
| Disease | Acute erythroleukemia - M6a subtype | 1.28e-03 | 8 | 203 | 2 | C2930975 | |
| Disease | Acute myeloid leukemia FAB-M6 | 1.28e-03 | 8 | 203 | 2 | C2930976 | |
| Disease | Acute erythroleukemia - M6b subtype | 1.28e-03 | 8 | 203 | 2 | C2930977 | |
| Disease | Acute erythroleukemia | 1.28e-03 | 8 | 203 | 2 | C2930974 | |
| Disease | Lymphoid leukemia | 1.28e-03 | 8 | 203 | 2 | C0023448 | |
| Disease | systemic lupus erythematosus | BACH2 MYT1 PSMD1 ANKRD27 TYK2 RTKN2 PTPRH FCGR2A FCGR3A FCGR3B AFF1 CCDC116 SLC6A16 ELOF1 | 1.35e-03 | 799 | 203 | 14 | MONDO_0007915 |
| Disease | aspartate aminotransferase measurement | GAB2 CDH20 FCGR2A FCGR3A FCGR3B HRG ATG7 PKD2L1 RNF213 LCT ELOF1 LEPR IGHG1 IGHG3 PLCE1 | 1.56e-03 | 904 | 203 | 15 | EFO_0004736 |
| Disease | skin aging measurement | 1.63e-03 | 181 | 203 | 6 | EFO_0008006 | |
| Disease | beta-1,4-glucuronyltransferase 1 measurement | 1.64e-03 | 9 | 203 | 2 | EFO_0801412 | |
| Disease | hyperprolactinemia (biomarker_via_orthology) | 1.64e-03 | 9 | 203 | 2 | DOID:12700 (biomarker_via_orthology) | |
| Disease | mitochondrial ubiquitin ligase activator of NFKB 1 measurement | 1.64e-03 | 9 | 203 | 2 | EFO_0801804 | |
| Disease | plexin-B2 measurement | 1.64e-03 | 9 | 203 | 2 | EFO_0021867 | |
| Disease | Alzheimer disease, educational attainment | 1.68e-03 | 247 | 203 | 7 | EFO_0011015, MONDO_0004975 | |
| Disease | serum gamma-glutamyl transferase measurement | NARS1 CSMD3 SLC38A1 MET FCGR3A FCGR3B KMT2A AFF1 JCAD IQCH CBLB EYS THADA SIGLEC1 PLCE1 | 1.74e-03 | 914 | 203 | 15 | EFO_0004532 |
| Disease | monocyte percentage of leukocytes | NRIP1 DENND4A PDGFRB BACH2 BCL6 BPI PTPRH FCGR3B CFAP206 AFF2 LEPR THADA KANSL1 | 1.75e-03 | 731 | 203 | 13 | EFO_0007989 |
| Disease | hematocrit | TDRD15 NRIP1 HIVEP2 HLCS BCL6 MET PRDM8 FCGR2A FCGR3A FCGR3B AFF1 JCAD ZAN USP37 NOSIP BCL11B | 1.78e-03 | 1011 | 203 | 16 | EFO_0004348 |
| Disease | intellectual disability (implicated_via_orthology) | 1.81e-03 | 75 | 203 | 4 | DOID:1059 (implicated_via_orthology) | |
| Disease | mood instability measurement | 1.96e-03 | 128 | 203 | 5 | EFO_0008475 | |
| Disease | axin-2 measurement | 2.04e-03 | 10 | 203 | 2 | EFO_0801400 | |
| Disease | Small Lymphocytic Lymphoma | 2.04e-03 | 10 | 203 | 2 | C0855095 | |
| Disease | B-CELL MALIGNANCY, LOW-GRADE | 2.04e-03 | 10 | 203 | 2 | C1868683 | |
| Disease | FEV/FEC ratio | HIVEP2 BACH2 NCAM1 GAB2 MET DST FCGR2A FCGR3A FCGR3B SYNE2 DTHD1 JCAD HSPG2 TEKT5 IKZF4 THADA HMCN1 TNS1 | 2.16e-03 | 1228 | 203 | 18 | EFO_0004713 |
| Disease | response to risperidone | 2.27e-03 | 38 | 203 | 3 | GO_0097336 | |
| Disease | vital capacity | HIVEP2 MYT1 DST AFF1 UTRN PLXNA1 HSPG2 IQCH LCT LEPR IFNGR1 ALX1 KANSL1 HMCN1 DISP2 TNS1 OTOG PLCE1 | 2.32e-03 | 1236 | 203 | 18 | EFO_0004312 |
| Disease | Paranoia | 2.49e-03 | 11 | 203 | 2 | C1456784 | |
| Disease | visual epilepsy (is_implicated_in) | 2.49e-03 | 11 | 203 | 2 | DOID:11832 (is_implicated_in) | |
| Disease | Ashkenazi Jewish disorders | 2.49e-03 | 11 | 203 | 2 | cv:CN118946 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LEYFECSNVPVSTIN | 531 | O75410 | |
| LYCPTCKVTVNSASQ | 221 | Q66K41 | |
| ERTSPCQDSSVNYGI | 66 | Q15699 | |
| CPSSYNILDNSKIIS | 56 | Q969T7 | |
| RPQIKCEQSYGTNSS | 576 | Q9BYV9 | |
| CVQASVPVFIYTSSI | 111 | P26439 | |
| IYPSVEDSQEVCTTS | 241 | O75143 | |
| VSQTQIPQYISRCSV | 1556 | Q14031 | |
| QDQATEPCRSLYTNL | 536 | Q8IYX3 | |
| ESVTVNTYSCLDPGI | 1001 | Q7Z407 | |
| VYQAVPRTSSTQCSS | 1866 | Q7Z407 | |
| CANATDVTTTPSVQY | 1396 | P13611 | |
| ACVQASVPVFIYTSS | 111 | P14060 | |
| VVNEECPTITRTYSL | 576 | Q8IUX7 | |
| TVDIVVLESSAQYCP | 336 | Q8IWK6 | |
| TLTTQCTATELYQAV | 441 | P51816 | |
| EYQCEVSNPVSSNRS | 211 | Q3KPI0 | |
| TRNDTASYKCETQNP | 206 | P06731 | |
| VALTCEPEIQNTTYL | 341 | P06731 | |
| TIASQTNCPLYVTKV | 241 | Q14195 | |
| EYTCQTGQTSLSDPV | 101 | P12318 | |
| TNPTVDYSDNLTRLC | 201 | Q9NRK6 | |
| GTRTPTVEYICTQQN | 111 | Q9Y376 | |
| SVFTTNPCRIQYCTQ | 396 | P56282 | |
| AQLIVEECPSTYSLT | 11 | Q9H9E1 | |
| NIFATIEPQISYVTC | 1056 | Q6DHV5 | |
| AQVPTKCSQSSAIYQ | 396 | A7MBM2 | |
| TVCLEEFQTPITYLS | 51 | P60002 | |
| QVCEDTVTYPLNSNV | 2126 | Q5H9R4 | |
| FSVPSTAYVVLTCIN | 1641 | Q8IZY2 | |
| RENCSQVYPPKDTST | 566 | Q8IYR0 | |
| SLTLSSCLIPQYNQE | 111 | Q7Z5Q5 | |
| DCLPKLSYQNSSSIV | 951 | Q7Z401 | |
| ERTCELIYLTQPSSS | 166 | P06400 | |
| ISYFNNCTVNPKESI | 401 | P06400 | |
| NTLVQDICYSPDTQK | 146 | P30039 | |
| VRPQDAGTYVCTATN | 3631 | P98160 | |
| QTSVDPQVLTYLCLQ | 791 | Q86VS3 | |
| TTIVICCSPSSYNES | 296 | P33176 | |
| ELQAYIAQCQDSPTS | 536 | Q9GZU1 | |
| YVCAVTRDSLSNATP | 221 | Q9Y314 | |
| SIQSTCQFESYILIP | 46 | Q96NW4 | |
| NCPLFTDSQINVTVY | 316 | Q8N6Y1 | |
| DLCYTTSSIPQLLVN | 71 | Q9GZK6 | |
| ITLQYSCAVSPTDCS | 11 | P04196 | |
| AKETTQNALQTPCYT | 191 | Q16644 | |
| FENCQTVALSATPTT | 1411 | Q5T1H1 | |
| SATCQVRTSYLPEEI | 291 | P78508 | |
| NVTVDVQSPACTSYQ | 791 | Q9NQS7 | |
| NSCYSTASVPQSIPE | 121 | Q6ZRS4 | |
| VNSSPSVCVPSLISY | 2121 | Q03001 | |
| SVCVPSLISYLTQTE | 2126 | Q03001 | |
| SIVEQTYAPAECVSQ | 26 | Q06546 | |
| SSSEQSCDTVIYIGP | 856 | Q2KJY2 | |
| CYSSTAPVSEVSITQ | 1241 | Q2KJY2 | |
| VSSPYSQGESTCETQ | 541 | Q9P266 | |
| NSNPTICINDLITEY | 606 | P50747 | |
| KTNRTSQDYDQLPSC | 881 | Q13191 | |
| AQTASKECQTSSPYT | 5991 | Q5CZC0 | |
| ELTVTNARYVPVSCE | 496 | Q9BW19 | |
| SKVYAVATSTNTPCA | 1031 | Q10570 | |
| STQVLLGDVYQSPCT | 271 | Q9Y5L3 | |
| QPTCSYQQISCLDSV | 576 | O15055 | |
| SPSYQQINCIDSVIR | 531 | P56645 | |
| QVTRVPVESCVQYTS | 506 | Q9UIW2 | |
| PSYIVCNTTSSDEVL | 1001 | Q9HCM2 | |
| NISIISDTSCDKSYP | 171 | Q9H2R5 | |
| YSPDGSVLTVACEQT | 176 | Q5QP82 | |
| CSYNSILSITVQEPG | 106 | Q8TE67 | |
| EVATYTFLQQLCPDS | 146 | P51570 | |
| RSNSTSVNPYCTREI | 136 | Q14005 | |
| SAVCQSRTSYIPEEI | 291 | Q99712 | |
| NSPTYCQTIVDTVAS | 311 | O94830 | |
| PLDSCGEQTITTLYT | 776 | P55160 | |
| QPLVASYLCSDVTSV | 76 | Q7Z3B3 | |
| VSYQTDRTDQTPCTP | 471 | Q5VZ66 | |
| YTSRLISNAPQNTCI | 686 | P09848 | |
| PYVCSTQSEKLTNTA | 581 | P48552 | |
| VQSLSAYPLNSSCVI | 741 | P48357 | |
| TPIPNQSESTCYEVA | 46 | Q13651 | |
| CYPTPSSSNDTREQV | 471 | O15230 | |
| PGNTSLCTRDYKITQ | 11 | Q9H244 | |
| NLSFIDVCYISSTVP | 66 | Q8NGI8 | |
| ARYNVTASICNTSPN | 576 | Q7Z2Q7 | |
| TVILNSPTSLVCEAY | 2586 | Q96RW7 | |
| LAFIDICYTTSNVPQ | 66 | Q9UGF6 | |
| ECSQNYTTPSGVIKS | 146 | O14786 | |
| VCITSFISPYTQDRN | 126 | O43252 | |
| QIITSNNYRESLPCT | 131 | Q7L622 | |
| EVQLCFSIYPSSNVE | 1381 | Q9P2D7 | |
| YVQETPLVLSRCSSV | 1151 | O95996 | |
| SESSDISQPYVVCRQ | 416 | Q96EP1 | |
| VDATDASYPSVNTCV | 2566 | Q9ULT8 | |
| CPAIGTLYNTNTLES | 81 | O95352 | |
| QLSGKDEPSSYICTT | 211 | Q9C0K0 | |
| EQYPTSLACVEIVNT | 1036 | P51587 | |
| CEEPQVKYSTLHTQS | 236 | Q8TCZ2 | |
| RSAYITPCTTSVSND | 171 | P56159 | |
| CLIPSSVQEYVSVVS | 146 | Q8TD84 | |
| ESLSRYVPQTCAVNS | 706 | Q9HBT6 | |
| IQSCAAQAVLTAPYS | 851 | Q5JV73 | |
| CEKVTNSVSSELQPY | 206 | P17213 | |
| YTCVEATPSALQANL | 61 | Q5VZ89 | |
| LETTVNYTDSQRPIC | 486 | P03951 | |
| LSDVTGPQVSCYITA | 176 | Q6ZMT9 | |
| TLEVSPNVCHSNIYS | 246 | P41182 | |
| QVVCSYQKPSRTTES | 111 | Q5U623 | |
| EYRCQTNLSTLSDPV | 86 | O75015 | |
| PLADCTTVTGYNTQL | 266 | A2RUH7 | |
| ASVVQYPDCKSSANT | 106 | P31273 | |
| TCVRITYCPTLQDQS | 221 | Q6UXX5 | |
| YSVSNTVVKTCNVRP | 756 | Q17RS7 | |
| IYCLNPQVTATFTVS | 541 | Q96G42 | |
| PQENTISGYSLLTCK | 271 | P03952 | |
| SNLPESVAYTCVNCT | 1611 | Q03164 | |
| SVQSQAPCQSEVSYV | 106 | Q5T749 | |
| VPSSSLGTQTYICNV | 71 | P01857 | |
| VPSSSLGTQTYTCNV | 71 | P01860 | |
| SQTDPVTLQYCCLTD | 611 | Q9BYK8 | |
| VSESVLCTPPNVSYA | 1166 | Q13255 | |
| CASQTTANDPYTVRS | 326 | Q99679 | |
| EYRCQTNLSTLSDPV | 86 | P08637 | |
| NITSPEVNYCLVTDL | 821 | Q7Z5N4 | |
| TIQGSIEYSCPASNE | 106 | P11474 | |
| CISELTPVISSVYTQ | 391 | Q9H2S9 | |
| IYTGNVTFSCSEPQI | 351 | Q8WYK1 | |
| CSISNPDFVIYSSVV | 181 | P35462 | |
| QLAIPVSSLNSQYCV | 201 | P15260 | |
| VVSCVYPSSEKNNSN | 131 | Q9NY27 | |
| PQSTYREATTVDCND | 46 | Q6UXK5 | |
| LQPSTDYEVCLTVSN | 586 | Q6UXK5 | |
| TCRATLINESPVLSY | 786 | P09619 | |
| PNINRVSTCYSEEIT | 161 | O14830 | |
| CTTVLDPLTNFYQIN | 2716 | Q6ZRI0 | |
| QVDLTGATCPYTLSN | 756 | Q86XP0 | |
| SQYCRPISTQSITST | 561 | Q9UQC2 | |
| SVSNSILECYTPAQT | 701 | P08581 | |
| ILECYTPAQTISTEF | 706 | P08581 | |
| EASYVNLPTIALCNT | 136 | P08865 | |
| APESYKNVTDVVNTC | 471 | Q9Y3I0 | |
| VYSCCTEESSITNTP | 176 | Q8IZC4 | |
| YTTILSCLIQTFPNQ | 1541 | O75691 | |
| IAQEPLYQCLVTTET | 1751 | P46939 | |
| LPSSLSAYLTQQVAC | 861 | Q6YHU6 | |
| LQVDETKYPSTCNVT | 721 | Q9GZN6 | |
| SYLVRLSETNPQDCS | 261 | Q96IW2 | |
| LTQSSQLYLETCLPA | 296 | O43776 | |
| ERTAACPNSSEVLYT | 6156 | Q8WXH0 | |
| IVYNIESKTPVSSCT | 1706 | B5MCY1 | |
| TSIEPNLTSDASVYC | 321 | Q9Y4C2 | |
| YCESQKLQEIPSSIS | 46 | Q86VH5 | |
| DLVVYENSSNPVCTL | 441 | O15226 | |
| VLQDSQDRCYSTPSG | 631 | Q6P3W6 | |
| VLQDSLDRCYSTPSV | 631 | Q86T75 | |
| YSLTIVSGQNVCPSN | 1871 | Q9P212 | |
| QEITVLSQCDSPYVT | 81 | Q9Y6E0 | |
| SYVPDTTISLSQCEK | 926 | Q5K651 | |
| DFCYSSTVVPQTLVN | 121 | Q8NGC0 | |
| FTSVYTTCDIPENAI | 26 | Q9NQV8 | |
| PSSGSVSLYEVERCQ | 316 | Q9NUX5 | |
| EQCPSVVSLLSESYN | 631 | Q99460 | |
| VDLTSACKISPASYN | 606 | Q7Z333 | |
| DQELTYTCTAQNPVS | 186 | Q9UIB8 | |
| YKIANVQTCPDESTS | 56 | Q96M29 | |
| SSSRQTVYELCVCPN | 261 | Q96LD1 | |
| CSNRQLVPSYSEAVV | 351 | Q8N4L1 | |
| VTNSISLVYLVCNTT | 4581 | Q9P2P6 | |
| EITVLSQCDSPYITR | 66 | O00506 | |
| SCSTPLSQANRYTKE | 766 | Q9NRA8 | |
| PSQSVEQTYSNEVHC | 341 | P51825 | |
| TTVKCTTLIEQQFTY | 441 | Q8TCG1 | |
| SCVYISSSPDEVALV | 501 | P98196 | |
| QVNITCEVFAYPSAT | 431 | P13591 | |
| ECDTKLYTSAPNTSQ | 421 | Q5QJE6 | |
| TKEEPLSQITAYCNS | 966 | Q63HN8 | |
| NIYQVSTAEQCRSSP | 466 | A0JNW5 | |
| SLITAIPITQEACYE | 1751 | Q8N2C7 | |
| SPCESVQELYSIAII | 146 | Q8N427 | |
| TLLGTSCEVNPYITQ | 171 | Q6T4P5 | |
| IVNVNPCASTYDETL | 481 | O95235 | |
| VTAYSETIVAAPNCT | 131 | Q6ZTI6 | |
| NYQEVSRTLCPSEAT | 121 | Q9NXL6 | |
| TAYVCENQACSVPIT | 761 | Q8TB22 | |
| KDNYQRVSSLSPSQC | 781 | Q9NS62 | |
| IYNIPGDSQTSVCIT | 221 | Q9HBL0 | |
| APVELRCNYSSSVSV | 36 | A0A0B4J262 | |
| YTALPLATVICSTNQ | 76 | P11172 | |
| ELVTLTCQVNSSYPA | 256 | Q9BZZ2 | |
| TCQVNSSYPAVSSIK | 261 | Q9BZZ2 | |
| NYTAIECETSPAAQQ | 1706 | Q86WI1 | |
| LSYTCRANNPISNVS | 196 | Q96A28 | |
| YCSENTSVPNESNKI | 686 | Q8NB14 | |
| EPQETAYRTQVSSCC | 56 | Q9P0L9 | |
| TNTVYETTCTPISKT | 1271 | Q4KWH8 | |
| TVTQLRPNATYSVCV | 521 | Q6EMK4 | |
| CQEYLPSQITILTTY | 1146 | Q9P2E3 | |
| TCEENSLPYQVSLNS | 86 | P35030 | |
| TIYVCREQPSSTVLQ | 431 | Q9NZI7 | |
| PELCTSAVSLYQIQE | 851 | Q8IYT8 | |
| LVSAAPSQTSVYLCA | 96 | A0A0A6YYG3 | |
| SATRAYTCPVITNLE | 466 | Q86T82 | |
| KPESNEQVLSCEYIT | 321 | Q8WWH5 | |
| EISSVSPESLNYCTT | 191 | Q16401 | |
| SQPVICQSSVYGTLE | 986 | Q5VWN6 | |
| NCSSLETRNKIPYES | 106 | Q9GZT5 | |
| SETPKQNYRDISCLS | 651 | P31629 | |
| ENRNLVSPAYCTQES | 91 | Q9NUQ3 | |
| TQSLCASTYPDTVTI | 656 | Q9HD43 | |
| TEAETVQVSCSYSQP | 1826 | Q702N8 | |
| ANSTNADTCTPKYVT | 256 | Q9H2H9 | |
| TYISVPKENSTLNCA | 126 | Q8IUR0 | |
| LATLTSQCLTYEPTQ | 841 | P29597 | |
| CLVYSIPTNSSKLQQ | 346 | O43264 | |
| QKYQVVNSPSCDSSL | 1331 | Q9Y493 | |
| AQKEYLSQSCPSVSN | 1701 | Q5THJ4 | |
| LSQSCPSVSNVEYPD | 1706 | Q5THJ4 | |
| TTEATAQCIPAYSTK | 381 | Q8N8K9 | |
| IYPQLSTTESQASCR | 21 | Q13459 | |
| PICEQNFDAYVSTLT | 1081 | Q01538 |